A detailed history of National Bank Of Canada transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, National Bank Of Canada holds 15,644,218 shares of BHC stock, worth $117 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
15,644,218
Previous 15,644,218 -0.0%
Holding current value
$117 Million
Previous $128 Million -0.0%
% of portfolio
0.18%
Previous 0.18%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$5.22 - $8.26 $120,503 - $190,682
-23,085 Reduced 0.15%
15,644,218 $128 Million
Q2 2024

Aug 02, 2024

BUY
$6.1 - $10.41 $36,654 - $62,553
6,009 Added 0.04%
15,667,303 $109 Million
Q1 2024

May 13, 2024

BUY
$7.77 - $10.61 $91,336 - $124,720
11,755 Added 0.08%
15,661,294 $166 Million
Q4 2023

Feb 06, 2024

SELL
$6.53 - $8.23 $79,568 - $100,282
-12,185 Reduced 0.08%
15,649,539 $126 Million
Q3 2023

Oct 10, 2023

BUY
$7.69 - $9.71 $19.1 Million - $24.1 Million
2,480,084 Added 18.81%
15,661,724 $129 Million
Q2 2023

Jul 26, 2023

BUY
$5.72 - $8.8 $223,663 - $344,097
39,102 Added 0.3%
13,181,640 $105 Million
Q1 2023

Apr 12, 2023

BUY
$6.28 - $9.85 $37,271 - $58,459
5,935 Added 0.05%
13,142,538 $106 Million
Q4 2022

Jan 24, 2023

BUY
$6.09 - $7.93 $79.4 Million - $103 Million
13,033,873 Added 12687.5%
13,136,603 $0
Q3 2022

Oct 13, 2022

BUY
$4.58 - $9.21 $31,340 - $63,024
6,843 Added 7.14%
102,730 $600,000
Q2 2022

Jul 28, 2022

SELL
$7.06 - $23.63 $5.36 Million - $17.9 Million
-759,296 Reduced 88.79%
95,887 $799,000
Q1 2022

May 05, 2022

BUY
$21.6 - $27.79 $14.9 Million - $19.2 Million
691,196 Added 421.49%
855,183 $19.5 Million
Q4 2021

Jan 24, 2022

BUY
$23.0 - $29.01 $3.77 Million - $4.76 Million
163,987 New
163,987 $4.53 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.7B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.